High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions

High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions

Patient response to P2Y12 inhibitor therapy is heterogeneous, and those with high on-treatment platelet reactivity (HTPR) are at an increased risk of thrombotic complications. The aim of our study was to determine whether selecting a high-risk patient group of individuals after complex percutaneous...

Full description

Bibliographic Details
Main Authors: Lukáš Urban MD, PhD, Škorňová Ingrid Ing, PhD, Jana Žolková Ing, PhD, Staško Ján MD, PhD, Tomáš Bolek MD, PhD, Matej Samoš MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-09-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296231199089

Internet

https://doi.org/10.1177/10760296231199089

Similar Items